CCRM Nordic developed an application note together with Celleo Biotech evaluating the Larkem V40 automated vial filling system within a CAR-T workflow.

The Centre for Commercialization of Regenerative Medicine (CCRM) Nordic is located at GoCo Health Innovation City in Mölndal, Gothenburg, Sweden with specialized infrastructure and expertise focused on development, manufacturing and commercialization of Advanced Therapy Medicinal Products (ATMPs). ATMP is the European Medicines Agency (EMA) classification of cell and gene therapy drugs, and tissue engineered drugs. These products must be produced to Good Manufacturing Practice (GMP) standards and complete clinical trials before applying for market approval and becoming available to patients. Organizations like CCRM ensure ATMPs are manufactured and controlled according to the required quality standards, strengthening the chances these novel therapeutics will make it to patients. CCRM Nordic is a not-for-profit infrastructure for commercialization of advanced therapies, based on the successful CCRM model founded in Toronto, Canada and formed as a public private partnership backed by an industry consortium and the Swedish Innovation agency Vinnova.